ETC
RAPT

Exchange Traded Concepts’s RAPT Therapeutics RAPT Stock Holding History

Exchange Traded Concepts’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,217
Closed -$139K – 1482
2025
Q1 		$139K Buy
14,217
+3,082
+28% +$30.3K ﹤0.01% 1059
2024
Q4 		$141K Hold
11,135
– – ﹤0.01% 1076
2024
Q3 		$179K Buy
11,135
+7,905
+245% +$160K ﹤0.01% 995
2024
Q2 		$78.8K Sell
3,230
-1,005
-24% -$46.4K ﹤0.01% 953
2024
Q1 		$304K Buy
4,235
+3,336
+371% +$464K 0.01% 791
2023
Q4 		$179K Buy
899
+228
+34% +$28.2K ﹤0.01% 800
2023
Q3 		$89.2K Sell
671
-154
-19% -$25.1K ﹤0.01% 941
2023
Q2 		$123K Buy
+825
New +$129K ﹤0.01% 903

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Exchange Traded Concepts's RAPT Position: Q2 2025 in Review

Exchange Traded Concepts sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 14,217 shares — an estimated $139K sold.

Exchange Traded Concepts first reported a position in RAPT in Q2 2023 and held it in 8 quarters. The position peaked at $304K in Q1 2024. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Exchange Traded Concepts reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 14,217 RAPT Therapeutics shares in Q2 2025, an estimated $139K.
  • Exchange Traded Concepts first reported a position in RAPT Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's RAPT Therapeutics position peaked at $304K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.